NCT00086255View on ClinicalTrials.gov

Tiagabine for the Treatment of Cocaine Dependence - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

June 30, 2004

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Tiagabine

Trial Locations (4)

45220

Cincinnati VA Medical Center, Cincinnati

45428

Dayton VA Medical Center, Dayton

77030

University of Texas Hlth Sci Ctr Houston, Houston

02215

Boston University Medical Center, Boston

All Listed Sponsors
collaborator

University of Cincinnati

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00086255 - Tiagabine for the Treatment of Cocaine Dependence - 1 | Biotech Hunter | Biotech Hunter